A Randomized Phase II Trial Evaluating Hight Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
The purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy
chosen for this study as well as a commonly used alternate form of brachytherapy called low
dose rate (or seed) brachytherapy. Investigators would like to understand how these
treatments control the prostate cancer and look at their short and long term treatment
related side effects.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society